Clinical Ophthalmology
Volume 15, 2021 - Issue
Open access
129
Views
5
CrossRef citations to date
0
Altmetric
Clinical Trial Report
Phase 3 Efficacy (Worse-Eye Analysis) and Long-Term Safety Evaluation of OTX-101 in Patients with Keratoconjunctivitis Sicca
John Sheppard1 Virginia Eye Consultants, Norfolk, VA, USACorrespondence[email protected]
View further author information
, View further author information
Mark Bergmann2 Apex Eye, Cincinnati, OH, USAView further author information
, Barry A Schechter3 Florida Eye Microsurgical Institute, Boynton Beach, FL, USAView further author information
, Jodi Luchs4 Florida Vision Institute, West Palm Beach, FL, USA
https://orcid.org/0000-0003-4634-9542View further author information
Abayomi Ogundele5 Medical Affairs, Sun Pharmaceutical Industries, Inc, Princeton, NJ, USAView further author information
& Paul Karpecki6 Kentucky Eye Institute, Lexington, KY, USA
https://orcid.org/0000-0003-1390-2532View further author information
Pages 129-140
|
Published online: 12 Jan 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.